Nonetheless, for instance, whereas Tfh was related to a poor prognostic in NSCLC, Tfr reported a good prognosis since it showed an essential immune-suppressive power in the development of NSCLC; although this ability changed depending on tumour stage [458]. The gene discussed is TFRC; the disease is neoplasm.